Enzyme new potential target in treating blood cancer

A discovery by a research team at the Sahlgrenska Academy at University of Gothenburg in Sweden may lead to new treatments for blood cancer and other types of cancer. By stopping the production of a specific enzyme, ICMT, researchers were able to alleviate disease symptoms in mice with blood cancer.

In many forms of cancer, the growth of tumors and their ability to spread are stimulated by a mutated gene that codes for a so-called RAS protein. This has led to intensive research into how to block the activity of these proteins.

University of Gothenburg